Associate Professor Rina Hui

Clinical Associate Professor
Medicine, Westmead Clinical School

Telephone +61 2 9845 5200
Fax +61 2 9845 6391

Map

Clinical Specialty

Oncology

Selected publications

Download citations: PDF RTF Endnote

Journals

  • Boyd, A., Stoodley, P., Richards, D., Hui, R., Harnett, P., Vo, K., Marwick, T., Thomas, L. (2017). Anthracyclines induce early changes in left ventricular systolic and diastolic function: A single centre study. PloS One, 12(4), 1-15. [More Information]
  • Antonia, S., Villegas, A., Daniel, D., Vicente, D., Murakami, S., Hui, R., Yokoi, T., Chiappori, A., Lee, K., de Wit, M., et al (2017). Durvalumab after chemoradiotherapy in stage III non�small-cell lung cancer. The New England Journal of Medicine, 377(20), 1919-1929. [More Information]
  • Dhillon, H., Bell, M., Van Der Ploeg, H., Turner, J., Kabourakis, M., Spencer, L., Lewis, C., Hui, R., Blinman, P., Clarke, S., Boyer, M., Vardy, J. (2017). Impact of physical activity on fatigue and quality of life in people with advanced lung cancer: A randomized controlled trial. Annals of Oncology, 28(8), 1889-1897. [More Information]
  • Hui, R., Garon, E., Goldman, J., Leighl, N., Hellmann, M., Patnaik, A., Gandhi, L., Eder, J., Ahn, M., Horn, L., et al (2017). Pembrolizumab as first-line therapy for patients with PD-L1-positive advanced non-small cell lung cancer: A phase 1 trial. Annals of Oncology, 28(4), 874-881. [More Information]
  • Fox, P., Balleine, R., Lee, C., Gao, B., Balakrishnar, B., Menzies, A., Yeap, S., Ali, S., Gebski, V., Provan, P., Liddle, C., Hui, R., Kefford, R., Wong, K., Wilcken, N., Gurney, H., et al (2016). Dose escalation of tamoxifen in patients with low endoxifen level: Evidence for therapeutic drug monitoring - The TADE study. Clinical Cancer Research, 22(13), 3164-3171. [More Information]
  • Wakade, D., Carlos Minano, G., Hwang, S., Chou, S., Hui, R., Fernandez Penas, P. (2016). PD-1 inhibitors induced bullous lichen planus-like reactions: A rare presentation and report of three cases. Melanoma Research, 26(4), 421-424. [More Information]
  • Reck, M., Rodriguez-Abreu, D., Robinson, A., Hui, R., Csoszi, T., Fulop, A., Gottfried, M., Peled, N., Tafreshi, A., Cuffe, S., et al (2016). Pembrolizumab versus Chemotherapy for PD-L1-Positive Non-Small-Cell Lung Cancer. The New England Journal of Medicine, 375(19), 1823-1833. [More Information]
  • Chatterjee, M., Turner, D., Felip, E., Lena, H., Cappuzzo, F., Horn, L., Garon, E., Hui, R., Arkenau, H., Gubens, M., et al (2016). Systematic evaluation of pembrolizumab dosing in patients with advanced non-small-cell lung cancer. Annals of Oncology, 27(7), 1291-1298. [More Information]
  • Garon, E., Rizvi, N., Hui, R., Leighl, N., Balmanoukian, A., Eder, J., Patnaik, A., Aggarwal, C., Gubens, M., Horn, L., et al (2015). Pembrolizumab for the Treatment of Non-Small-Cell Lung Cancer. The New England Journal of Medicine, 372(71), 2018-2028. [More Information]
  • Yee, J., Davis, G., Beith, J., Wilcken, N., Currow, D., Emery, J., Phillips, J., Martin, A., Hui, R., Harrison, M., Kilbreath, S., et al (2014). Physical activity and fitness in women with metastatic breast cancer. Journal of Cancer Survivorship, 8(4), 647-656. [More Information]
  • Stoodley, P., Richards, D., Boyd, A., Hui, R., Harnett, P., Meikle, S., Clarke, J., Thomas, L. (2013). Altered left ventricular longitudinal diastolic function correlates with reduced systolic function immediately after anthracycline chemotherapy. European Heart Journal - Cardiovascular Imaging, 14(3), 228-234. [More Information]
  • Carus, A., Gurney, H., Gebski, V., Harnett, P., Hui, R., Kefford, R., Wilcken, N., Ladekarl, M., von der Maase, H., Donskov, F. (2013). Impact of baseline and nadir neutrophil index in non-small cell lung cancer and ovarian cancer patients: Assessment of chemotherapy for resolution of unfavourable neutrophilia. Journal of Translational Medicine, 11(1), 1-10. [More Information]
  • Stoodley, P., Richards, D., Boyd, A., Hui, R., Harnett, P., Meikle, S., Byth Wilson, K., Stuart, K., Clarke, J., Thomas, L. (2013). Left ventricular systolic function in HER2/neu negative breast cancer patients treated with anthracycline chemotherapy: A comparative analysis of left ventricular ejection fraction and myocardial strain imaging over 12 months. European Journal of Cancer, 49(16), 3396-3403. [More Information]
  • Butow, P., Sze, M., Eisenbruch, M., Bell, M., Aldridge, L., Abdo, S., Mikhail (nee Tanious), M., Dong, S., Iedema, R., Vardy, J., Hui, R., et al (2013). Should culture affect practice? A comparison of prognostic discussions in consultations with immigrant versus native-born cancer patients. Patient Education and Counseling, 92(2), 246-252. [More Information]
  • Venkateswaran, L., Butow, P., Jansen, J., Wilcken, N., WONG, M., Hui, R., Szonyi, G., Gebski, V., Naganathan, V., Horvath, L., Tattersall, M. (2012). Decision making in older patients with advanced cancer: Does doctor know best? The Medical Journal of Australia, 196(1), 35-39. [More Information]
  • Mitchison, D., Butow, P., Sze, M., Aldridge, L., Hui, R., Vardy, J., Eisenbruch, M., Iedema, R., Goldstein, D. (2012). Prognostic communication preferences of migrant patients and their relatives. Psycho-Oncology, 21(5), 496-504. [More Information]
  • Stoodley, P., Tanous, D., Richards, D., Meikle, S., Clarke, J., Hui, R., Thomas, L. (2012). Trastuzumab-Induced Cardiotoxicity: The Role of Two-Dimensional Myocardial Strain Imaging in Diagnosis and Management. Echocardiography, 29(6), E137-E140. [More Information]
  • Butow, P., Bell, M., Goldstein, D., Sze, M., Aldridge, L., Abdo, S., Mikhail (nee Tanious), M., Dong, S., Iedema, R., Ashgari, R., Hui, R., et al (2011). Grappling with cultural differences; Communication between oncologists and immigrant cancer patients with and without interpreters. Patient Education and Counseling, 84, 398-405. [More Information]
  • Butow, P., Goldstein, D., Bell, M., Sze, M., Aldridge, L., Abdo, S., Mikhail (nee Tanious), M., Dong, S., Iedema, R., Vardy, J., et al (2011). Interpretation in Consultations With Immigrant Patients With Cancer: How Accurate Is It? Journal of Clinical Oncology, 29(20), 2801-2807. [More Information]
  • Stoodley, P., Richards, D., Meikle, S., Clarke, J., Hui, R., Thomas, L. (2011). The potential role of echocardiographic strain imaging for evaluating cardiotoxicity due to cancer therapy. Heart, Lung and Circulation, 20, 3-9. [More Information]
  • Stoodley, P., Richards, D., Hui, R., Boyd, A., Harnett, P., Meikle, S., Clarke, J., Thomas, L. (2011). Two-dimensional myocardial strain imaging detects changes in left ventricular systolic function immediately after anthracycline chemotherapy. European Journal of Echocardiography, 12, 945-952. [More Information]
  • Underhill, C., Hui, R., Links, M., Hawson, G., Chern, B., Yip, D., Blackwell, T., Crombie, C., Boyer, M. (2005). Phase II study of docetaxel and celecoxib as first or second line therapy in patients with advanced NSCLC. Lung Cancer, 49(Sup.2), S272-S273.
  • Burge, M., Joshua, A., McNeil, C., Hui, R., Boyer, M., Abraham, R. (2005). Retrospective review of pemetrexed with or without platinum in malignant mesothelioma: The Australian 'Special Access Scheme' experience. Asia-Pacific Journal of Clinical Oncology, 1(1), 47-52.

2017

  • Boyd, A., Stoodley, P., Richards, D., Hui, R., Harnett, P., Vo, K., Marwick, T., Thomas, L. (2017). Anthracyclines induce early changes in left ventricular systolic and diastolic function: A single centre study. PloS One, 12(4), 1-15. [More Information]
  • Antonia, S., Villegas, A., Daniel, D., Vicente, D., Murakami, S., Hui, R., Yokoi, T., Chiappori, A., Lee, K., de Wit, M., et al (2017). Durvalumab after chemoradiotherapy in stage III non�small-cell lung cancer. The New England Journal of Medicine, 377(20), 1919-1929. [More Information]
  • Dhillon, H., Bell, M., Van Der Ploeg, H., Turner, J., Kabourakis, M., Spencer, L., Lewis, C., Hui, R., Blinman, P., Clarke, S., Boyer, M., Vardy, J. (2017). Impact of physical activity on fatigue and quality of life in people with advanced lung cancer: A randomized controlled trial. Annals of Oncology, 28(8), 1889-1897. [More Information]
  • Hui, R., Garon, E., Goldman, J., Leighl, N., Hellmann, M., Patnaik, A., Gandhi, L., Eder, J., Ahn, M., Horn, L., et al (2017). Pembrolizumab as first-line therapy for patients with PD-L1-positive advanced non-small cell lung cancer: A phase 1 trial. Annals of Oncology, 28(4), 874-881. [More Information]

2016

  • Fox, P., Balleine, R., Lee, C., Gao, B., Balakrishnar, B., Menzies, A., Yeap, S., Ali, S., Gebski, V., Provan, P., Liddle, C., Hui, R., Kefford, R., Wong, K., Wilcken, N., Gurney, H., et al (2016). Dose escalation of tamoxifen in patients with low endoxifen level: Evidence for therapeutic drug monitoring - The TADE study. Clinical Cancer Research, 22(13), 3164-3171. [More Information]
  • Wakade, D., Carlos Minano, G., Hwang, S., Chou, S., Hui, R., Fernandez Penas, P. (2016). PD-1 inhibitors induced bullous lichen planus-like reactions: A rare presentation and report of three cases. Melanoma Research, 26(4), 421-424. [More Information]
  • Reck, M., Rodriguez-Abreu, D., Robinson, A., Hui, R., Csoszi, T., Fulop, A., Gottfried, M., Peled, N., Tafreshi, A., Cuffe, S., et al (2016). Pembrolizumab versus Chemotherapy for PD-L1-Positive Non-Small-Cell Lung Cancer. The New England Journal of Medicine, 375(19), 1823-1833. [More Information]
  • Chatterjee, M., Turner, D., Felip, E., Lena, H., Cappuzzo, F., Horn, L., Garon, E., Hui, R., Arkenau, H., Gubens, M., et al (2016). Systematic evaluation of pembrolizumab dosing in patients with advanced non-small-cell lung cancer. Annals of Oncology, 27(7), 1291-1298. [More Information]

2015

  • Garon, E., Rizvi, N., Hui, R., Leighl, N., Balmanoukian, A., Eder, J., Patnaik, A., Aggarwal, C., Gubens, M., Horn, L., et al (2015). Pembrolizumab for the Treatment of Non-Small-Cell Lung Cancer. The New England Journal of Medicine, 372(71), 2018-2028. [More Information]

2014

  • Yee, J., Davis, G., Beith, J., Wilcken, N., Currow, D., Emery, J., Phillips, J., Martin, A., Hui, R., Harrison, M., Kilbreath, S., et al (2014). Physical activity and fitness in women with metastatic breast cancer. Journal of Cancer Survivorship, 8(4), 647-656. [More Information]

2013

  • Stoodley, P., Richards, D., Boyd, A., Hui, R., Harnett, P., Meikle, S., Clarke, J., Thomas, L. (2013). Altered left ventricular longitudinal diastolic function correlates with reduced systolic function immediately after anthracycline chemotherapy. European Heart Journal - Cardiovascular Imaging, 14(3), 228-234. [More Information]
  • Carus, A., Gurney, H., Gebski, V., Harnett, P., Hui, R., Kefford, R., Wilcken, N., Ladekarl, M., von der Maase, H., Donskov, F. (2013). Impact of baseline and nadir neutrophil index in non-small cell lung cancer and ovarian cancer patients: Assessment of chemotherapy for resolution of unfavourable neutrophilia. Journal of Translational Medicine, 11(1), 1-10. [More Information]
  • Stoodley, P., Richards, D., Boyd, A., Hui, R., Harnett, P., Meikle, S., Byth Wilson, K., Stuart, K., Clarke, J., Thomas, L. (2013). Left ventricular systolic function in HER2/neu negative breast cancer patients treated with anthracycline chemotherapy: A comparative analysis of left ventricular ejection fraction and myocardial strain imaging over 12 months. European Journal of Cancer, 49(16), 3396-3403. [More Information]
  • Butow, P., Sze, M., Eisenbruch, M., Bell, M., Aldridge, L., Abdo, S., Mikhail (nee Tanious), M., Dong, S., Iedema, R., Vardy, J., Hui, R., et al (2013). Should culture affect practice? A comparison of prognostic discussions in consultations with immigrant versus native-born cancer patients. Patient Education and Counseling, 92(2), 246-252. [More Information]

2012

  • Venkateswaran, L., Butow, P., Jansen, J., Wilcken, N., WONG, M., Hui, R., Szonyi, G., Gebski, V., Naganathan, V., Horvath, L., Tattersall, M. (2012). Decision making in older patients with advanced cancer: Does doctor know best? The Medical Journal of Australia, 196(1), 35-39. [More Information]
  • Mitchison, D., Butow, P., Sze, M., Aldridge, L., Hui, R., Vardy, J., Eisenbruch, M., Iedema, R., Goldstein, D. (2012). Prognostic communication preferences of migrant patients and their relatives. Psycho-Oncology, 21(5), 496-504. [More Information]
  • Stoodley, P., Tanous, D., Richards, D., Meikle, S., Clarke, J., Hui, R., Thomas, L. (2012). Trastuzumab-Induced Cardiotoxicity: The Role of Two-Dimensional Myocardial Strain Imaging in Diagnosis and Management. Echocardiography, 29(6), E137-E140. [More Information]

2011

  • Butow, P., Bell, M., Goldstein, D., Sze, M., Aldridge, L., Abdo, S., Mikhail (nee Tanious), M., Dong, S., Iedema, R., Ashgari, R., Hui, R., et al (2011). Grappling with cultural differences; Communication between oncologists and immigrant cancer patients with and without interpreters. Patient Education and Counseling, 84, 398-405. [More Information]
  • Butow, P., Goldstein, D., Bell, M., Sze, M., Aldridge, L., Abdo, S., Mikhail (nee Tanious), M., Dong, S., Iedema, R., Vardy, J., et al (2011). Interpretation in Consultations With Immigrant Patients With Cancer: How Accurate Is It? Journal of Clinical Oncology, 29(20), 2801-2807. [More Information]
  • Stoodley, P., Richards, D., Meikle, S., Clarke, J., Hui, R., Thomas, L. (2011). The potential role of echocardiographic strain imaging for evaluating cardiotoxicity due to cancer therapy. Heart, Lung and Circulation, 20, 3-9. [More Information]
  • Stoodley, P., Richards, D., Hui, R., Boyd, A., Harnett, P., Meikle, S., Clarke, J., Thomas, L. (2011). Two-dimensional myocardial strain imaging detects changes in left ventricular systolic function immediately after anthracycline chemotherapy. European Journal of Echocardiography, 12, 945-952. [More Information]

2005

  • Underhill, C., Hui, R., Links, M., Hawson, G., Chern, B., Yip, D., Blackwell, T., Crombie, C., Boyer, M. (2005). Phase II study of docetaxel and celecoxib as first or second line therapy in patients with advanced NSCLC. Lung Cancer, 49(Sup.2), S272-S273.
  • Burge, M., Joshua, A., McNeil, C., Hui, R., Boyer, M., Abraham, R. (2005). Retrospective review of pemetrexed with or without platinum in malignant mesothelioma: The Australian 'Special Access Scheme' experience. Asia-Pacific Journal of Clinical Oncology, 1(1), 47-52.

To update your profile click here. For support on your academic profile contact .